Search research articles
Contact Us
Filters
Showing results (291-300 of 703) with videos related to
Page
of 71
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma
J H Lee, G V Long, S Boyd, et al.
Cancers
|
August 14, 2020
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
Russell J Diefenbach, Jenny H Lee, Alexander M Menzies, et al.
The Australasian Journal of Dermatology
|
February 21, 2022
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma
Thomas E Pennington, Cathy Yunjia Zhao, Andrew J Colebatch, et al.
Oncoimmunology
|
October 21, 2016
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
E Liniker, A M Menzies, B Y Kong, et al.
Plos One
|
April 3, 2020
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
Kelly J McKelvey, Amanda L Hudson, Ramyashree Prasanna Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915
Georgina V Long, Hao Tang, Keyur Desai, et al.
Biomarker Research
|
November 21, 2017
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Su Yin Lim, Jenny H Lee, Sarah J Welsh, et al.
Oncoimmunology
|
February 1, 2020
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
Tuba N Gide, Ines P Silva, Camelia Quek, et al.
Page
of 71
Search research articles
Search
Showing results (291-300 of 703) with videos related to
Sort By:
Page
of 71
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma
J H Lee, G V Long, S Boyd, et al.
Cancers
|
August 14, 2020
Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
Russell J Diefenbach, Jenny H Lee, Alexander M Menzies, et al.
The Australasian Journal of Dermatology
|
February 21, 2022
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma
Thomas E Pennington, Cathy Yunjia Zhao, Andrew J Colebatch, et al.
Oncoimmunology
|
October 21, 2016
Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
E Liniker, A M Menzies, B Y Kong, et al.
Plos One
|
April 3, 2020
Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model
Kelly J McKelvey, Amanda L Hudson, Ramyashree Prasanna Kumar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915
Georgina V Long, Hao Tang, Keyur Desai, et al.
Biomarker Research
|
November 21, 2017
Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients
Su Yin Lim, Jenny H Lee, Sarah J Welsh, et al.
Oncoimmunology
|
February 1, 2020
Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients
Tuba N Gide, Ines P Silva, Camelia Quek, et al.
Page
of 71